Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03062111 · ClinicalTrials.gov registry record · NA
Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)
A NA study, sponsored by Boston University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03062111 is a NA study that was terminated before completion, run by Boston University. The registered enrollment target is 3 participants.
The verdict
NCT03062111, a NA study, was terminated before completion, sponsored by Boston University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Benign prostatic hyperplasia (BPH) refers to the proliferation of smooth muscle and epithelial cells of the prostate gland. The enlarged gland has the potential to result in lower urinary tract symptoms (LUTS) secondary to either bladder outlet obstruction or increased muscle tone and resistance, or both. For decades transurethral resection of the prostate (TURP) has been the gold standard for treatment of symptomatic BPH that is refractory to nonoperative management. This is a surgical intervention aimed to reduce the size of the prostate gland. However, over the past fifteen years, many alternative therapies have been introduced including laser enucleation of the prostate (LEP). LEP has numerous advantages including decreased blood loss and length of hospital stay as well as increased effectiveness and safety for large prostate gland sizes (\>80g).
Interventions
- PROCEDURE ProTouch Laser Enucleation of Prostate (LEP)
- PROCEDURE Transurethral Resection of Prostate (TURP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-10-23 |
| Est. Completion | 2021-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03062111
The ClinicalTrials.gov registry entry for NCT03062111 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ProTouch Laser Enucleation of Prostate (LEP) is the first listed.
NCT03062111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03062111 about?
NCT03062111 is a clinical study titled "Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)". Benign prostatic hyperplasia (BPH) refers to the proliferation of smooth muscle and epithelial cells of the prostate gland. The enlarged gland has the potential to result in lower urinary tract symptoms (LUTS) secondary to either bladder outlet obstruction or increased muscle tone and resistance, or...
What is the current status of trial NCT03062111?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-10-23. Estimated completion is 2021-01-15.
What interventions are being tested in trial NCT03062111?
The interventions under investigation include: ProTouch Laser Enucleation of Prostate (LEP) (PROCEDURE), Transurethral Resection of Prostate (TURP) (PROCEDURE).
Who is sponsoring clinical trial NCT03062111?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.